Altimmune, Inc. (NASDAQ: ALT), a clinical-stage biopharmaceutical company, is currently making waves in the healthcare sector with its focus on innovative therapies for serious liver diseases. With a market capitalization..
Investors eyeing opportunities in the healthcare sector may find Organogenesis Holdings Inc. (NASDAQ: ORGO) an intriguing prospect, especially given its potential upside of 56.25% based on current analyst target prices...
Treace Medical Concepts, Inc. (NASDAQ: TMCI) is garnering attention within the healthcare sector, specifically in the medical devices industry. With a market capitalization of $252.01 million, this United States-based company..
MBX Biosciences, Inc. (NASDAQ: MBX), a clinical-stage biopharmaceutical company, is capturing investor attention with a promising 77.09% potential upside, according to the latest analyst ratings. This biotechnology firm, based in..
Bioventus Inc. (NASDAQ: BVS), a prominent player in the healthcare sector specializing in medical devices, has captured the attention of investors with its potential for substantial stock appreciation. This Durham,..
Celcuity Inc. (NASDAQ: CELC) is gaining significant attention in the biotechnology sector, not just for its cutting-edge research in cancer therapies but also for its promising market potential. The company..
InnovAge Holding Corp. (NASDAQ: INNV) is a player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of $1.24 billion, InnovAge focuses on delivering..
Upstream Bio, Inc. (UPB), a clinical-stage biotechnology company, has caught the attention of investors with a staggering potential upside of 584.46%, according to the latest analyst ratings. Operating within the..
Sana Biotechnology, Inc. (NASDAQ: SANA), a pioneering entity in the biotechnology sector, has recently caught the attention of investors due to its promising potential for substantial stock price appreciation. Currently..
Investors with an eye on the healthcare sector may find Claritev Corporation (CTEV) particularly intriguing, especially given its impressive potential upside of 89.07%. Operating within the Health Information Services industry,..
Investors eyeing SIGA Technologies Inc. (NASDAQ: SIGA), a key player in the healthcare sector, are met with a mixed bag of financial metrics that warrant a closer look. With a..
AbCellera Biologics Inc. (NASDAQ: ABCL), a Canadian biotechnology innovator, is capturing the attention of investors with its cutting-edge approach to developing antibody-based medicines. Despite the recent volatility in its stock..
Cel-Sci Corporation (NASDAQ: CVM) is capturing the attention of investors, not just for its innovative approach in the biotech sector, but also for its eye-catching potential upside of 541.03%. With..
REGENXBIO Inc. (NASDAQ: RGNX) stands out in the biotechnology sector with a promising prospect for investors seeking substantial growth potential. This clinical-stage company, headquartered in Rockville, Maryland, is at the..
Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) sits at the intersection of biotechnology and innovation, offering a compelling yet challenging landscape for investors. As a trailblazer in the cell engineering sector,..
Sonida Senior Living, Inc. (SNDA) is a prominent player in the healthcare sector, focusing on medical care facilities specifically tailored for senior housing communities in the United States. With a..
Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) stands at the intersection of biotechnology and innovation, offering investors a unique opportunity within the healthcare sector. With a market capitalization of $2.67 billion,..
EyePoint, Inc. (NASDAQ: EYPT) is catching the attention of investors with a staggering potential upside of 648.82%, according to analyst ratings. Despite its current challenges, this biotech company could prove..
AtaiBeckley Inc. (NASDAQ: ATAI) presents a compelling opportunity for investors seeking exposure to the innovative and rapidly evolving field of mental health treatments. With its robust pipeline of next-generation therapies,..
Humacyte, Inc. (NASDAQ: HUMA) is capturing the attention of investors with its groundbreaking biotechnology solutions and a remarkable potential upside of 263.45%. As a pioneer in the healthcare sector, Humacyte..
